Revolution Medicines, Inc. Other Non-Current Assets decreased by 2.0% to $14.48M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.3%, from $13.13M to $14.48M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Assets shows an upward trend with a 117.3% CAGR.
Significant changes may indicate shifts in long-term operational strategy or changes in accounting for specific non-core assets.
This captures miscellaneous long-term assets that do not fit into specific categories like property, plant, equipment, o...
Varies widely by company; usually represents a small percentage of total assets.
non_current_assets_other_assets_noncurrent| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $264.00K | $264.00K | $758.00K | $851.00K | $725.00K | $856.00K | $2.86M | $2.77M | $2.69M | $11.35M | $7.03M | $4.16M | $8.27M | $10.28M | $1.74M | $13.13M | $31.42M | $14.87M | $14.78M | $14.48M |
| QoQ Change | — | +0.0% | +187.1% | +12.3% | -14.8% | +18.1% | +233.8% | -3.0% | -2.9% | +321.9% | -38.1% | -40.9% | +98.9% | +24.2% | -83.0% | +653.8% | +139.3% | -52.7% | -0.6% | -2.0% |
| YoY Change | — | — | — | — | +174.6% | +224.2% | +276.9% | +225.7% | +271.2% | >999% | +146.1% | +50.0% | +207.5% | -9.5% | -75.2% | +215.7% | +279.7% | +44.7% | +748.4% | +10.3% |